| Dokumendiregister | Ravimiamet |
| Viit | MSO-1/585-1 |
| Registreeritud | 30.01.2026 |
| Sünkroonitud | 02.02.2026 |
| Liik | Sissetulev kiri |
| Funktsioon | MSO Meditsiiniseadmed |
| Sari | MSO-1 Eesti ja Euroopa Liidu ametiasutuste vaheline meditsiiniseadmetega seotud kirjavahetus |
| Toimik | MSO-1/2026 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | European Commission |
| Saabumis/saatmisviis | European Commission |
| Vastutaja | Jevgenija Tamm (RA, Meditsiiniseadmete osakond) |
| Originaal | Ava uues aknas |
From: "[email protected]" <[email protected]>
Sent: Tue, 20 Jan 2026 15:46:57 +0000
To: "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "'[email protected]'" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "[email protected]" <[email protected]>; "'[email protected]'" <[email protected]>
Cc: "[email protected]" <[email protected]>; SAUER Aisha <[email protected]>; ARMAS Federica <[email protected]>; ROSENDAHL Jennifer <[email protected]>; "[email protected]" <[email protected]>; TKACHENKO Olga <[email protected]>
Subject: EURL applications survey
|
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Dear colleagues,
As discussed during the IVD WG coordination call on the 15th of January, the submission deadline for the candidate EURLs in most Member States has passed or is approaching soon. To prepare for the next steps, we would like to gather information about the applications you received in a survey.
The information you provide will help the Commission to establish the Selection Board that will select the EURLs to be designated after performing a completeness and compliance check of the applications and considering the testing capacities of the candidate laboratories.
The survey can be accessed here: https://ec.europa.eu/eusurvey/runner/eurls-secondwave
Please feel free to forward the link to the person responsible in your Member State. The deadline for sending replies to this survey is Wednesday 4 February 2026 COB. Please do not hesitate to contact us on [email protected] if you have any questions related to the survey.
Kind regards,
JRC and SANTE EURL team